COLORADO SPRINGS, Colo., The Spectranetics Corporation today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission of the Bridge Occlusion Balloon. Building on the ...
The Spectranetics Corp. said it received clearance of its bridge occlusion balloon for temporary vessel occlusion in cardiac lead extraction procedures. The Colorado Springs, Colorado-based company ...
Please provide your email address to receive an email when new articles are posted on . A recent recall of a bridge occlusion catheter has been classified as class I, the most serious kind, due to the ...
Spectranetics reached a number of important milestones during the second quarter. Our highlights include, total revenue for the quarter reached $30 million driven by Lead Management revenue growth of ...
COLORADO SPRINGS, Colo., Jul 01, 2010 (BUSINESS WIRE) -- Spectranetics Corporation /quotes/comstock/15*!spnc/quotes/nls/spnc (SPNC 5.19, +0.03, +0.58%) today ...
The U.S. FDA’s final guidance for clinical decision support (CDS) systems may be the subject of two citizen’s petitions requesting the agency scrap the guidance ...
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq:SPNC) today announced an agreement with ThermopeutiX, Inc. to commercialize the TAPAS catheter, a therapeutic infusion ...
ORLANDO, Florida — Transvenous extraction of unused pacemaker or defibrillator leads poses a higher risk for death as an acute complication when it's performed by using a laser-based extraction sheath ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results